Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bangkok Genomics Innovation PCL's cash flow for dividends for the
six
months ended in Jun. 2026 was ฿-30.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2026 was ฿-30.0 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Bangkok Genomics Innovation PCL's quarterly payment of dividends
declined
from Jun. 2025 (฿-28.1 Mil) to Dec. 2025 (฿-0.0 Mil) but then
increased
from Dec. 2025 (฿-0.0 Mil) to Jun. 2026 (฿-30.0 Mil).
Bangkok Genomics Innovation PCL's annual payment of dividends
declined
from Dec. 2023 (฿-44.0 Mil) to Dec. 2024 (฿0.0 Mil) but then
increased
from Dec. 2024 (฿0.0 Mil) to Dec. 2025 (฿-28.1 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL Cash Flow for Dividends Chart
Bangkok Genomics Innovation PCL Cash Flow for Dividends Calculation
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ฿-30.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of ฿-30.0 Mil mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Cash Flow for Dividends of ฿-30.0 Mil as of Jun. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bangkok Genomics Innovation PCL and its competitors.
Is Bangkok Genomics Innovation PCL's Cash Flow for Dividends too high?
Bangkok Genomics Innovation PCL's current Cash Flow for Dividends is ฿-30.0 Mil. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Cash Flow for Dividends compare to TMO and DHR?
Bangkok Genomics Innovation PCL's Cash Flow for Dividends of ฿-30.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Diagnostics & Research company?
A good Cash Flow for Dividends depends on the Medical Diagnostics & Research industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bangkok Genomics Innovation PCL and its competitors. Bangkok Genomics Innovation PCL's current Cash Flow for Dividends is ฿-30.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Cash Flow for Dividends of ฿-30.0 Mil. The current Cash Flow for Dividends is ฿-30.0 Mil. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Cash Flow for Dividends is ฿-30.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
